Umbralisib R-enantiomer (Synonyms: TGR-1202 R-enantiomer; RP5264 R-enantiomer) |
Catalog No.GC37855 |
L'énantiomère R de l'umbralisib (énantiomère R du TGR-1202) est un inhibiteur de PI3Kδ, qui est l'énantiomère le moins actif du TGR-1202.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1532533-69-9
Sample solution is provided at 25 µL, 10mM.
Umbralisib R-enantiomer (TGR-1202 R-enantiomer) is a PI3Kδ inhibitor, which is the less active enantiomer of TGR-1202. PI3Kδ
Umbralisib R-enantiomer (TGR-1202 R-enantiomer) (Formula A) exhibits a 50% inhibitory concentration (IC50) with respect to the δ type PI3-kinase that is at least 20-fold lower than the inhibitor's IC50 with respect to the rest of the other PI3K isoforms (i.e., a, β, and γ)[1].
[1]. Michael Weiss, et al. Combination of anti-cd20 antibody and pi3 kinase selective inhibitor. WO2014071125A1.
Average Rating: 5
(Based on Reviews and 4 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *